NSE › Healthcare

Concord Biotech Limited (CONCORDBIO)

NSE · Healthcare · Biotechnology

₹1,414.60-0.44%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹326 cr

Revenue YoY

-24.1%

Net profit

₹89 cr

Profit YoY

-36.8%

EPS

₹8.46

EPS estimate

₹8.90

Net margin

27.2%

EPS came in at 8.46 against a street estimate of 8.90 — a miss of 4.9%.

Key statistics

Market cap

₹14,698 cr

P/E

48.5

Forward P/E

0.0

P/B

7.37

Book value

₹192.81

EPS (TTM)

₹28.98

52-week high

₹1,779.83

52-week low

₹981.13

50-day MA

₹1,275.04

200-day MA

₹1,248.65

Beta

0.42

Analyst view

with an average price target of ₹1,216.00.

Shareholding

Promoters

72.48%

Institutions

12.36%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Concord Biotech Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.